back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-11-12 14:34 Tx date 2025-11-10 |
$CIII
Cytophage Technologies Ltd. |
Kalcevich, Julius John
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$5,000
+12,500 vol $0.40 each |
87,500 | |
| Filed 2025-11-12 14:33 Tx date 2025-11-10 |
$CIII
Cytophage Technologies Ltd. |
Kalcevich, Julius John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$5,000
+25,000 vol $0.20 each |
435,000 | |
| Filed 2025-11-12 14:05 Tx date 2025-11-10 |
$CIII
Cytophage Technologies Ltd. |
Sorkin, Michael
4 - Director of Issuer
Holder: Debra S Sorkin Revocable Trust (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$25,000
+62,500 vol $0.40 each |
162,500 | |
| Filed 2025-11-12 14:02 Tx date 2025-11-10 |
$CIII
Cytophage Technologies Ltd. |
Sorkin, Michael
4 - Director of Issuer
Holder: Debra S Sorkin Revocable Trust (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$25,000
+125,000 vol $0.20 each |
475,000 | |
| Filed 2025-08-20 13:41 Tx date 2025-06-10 |
$CIII
Cytophage Technologies Ltd. |
COCHRANE, MICHAEL
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$15,000
+75,000 vol $0.20 each |
175,000 | |
| Filed 2025-08-20 13:32 Tx date 2025-07-31 |
$CIII
Cytophage Technologies Ltd. |
COCHRANE, MICHAEL
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+50,000 vol |
225,000 | |
| Filed 2025-08-12 18:40 Tx date 2025-07-31 |
$CIII
Cytophage Technologies Ltd. |
COCHRANE, MICHAEL
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+75,000 vol |
||
| Filed 2025-08-14 14:50 Tx date 2025-07-31 |
$CIII
Cytophage Technologies Ltd. |
Sorkin, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+100,000 vol |
450,000 | |
| Filed 2025-08-14 14:47 Tx date 2024-06-26 |
$CIII
Cytophage Technologies Ltd. |
Sorkin, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
350,000 | ||
| Filed 2025-08-14 14:15 Tx date 2025-07-31 |
$CIII
Cytophage Technologies Ltd. |
Gabor, Robert Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+100,000 vol |
200,000 | |
| Filed 2025-08-14 14:06 Tx date 2025-07-31 |
$CIII
Cytophage Technologies Ltd. |
Theriault, Steven Serge
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$17,500
+50,000 vol $0.35 each |
150,000 | |
| Filed 2025-08-14 14:04 Tx date 2025-07-31 |
$CIII
Cytophage Technologies Ltd. |
Theriault, Steven Serge
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+100,000 vol |
100,000 | |
| Filed 2025-08-14 14:00 Tx date 2024-02-02 |
$CIII
Cytophage Technologies Ltd. |
Theriault, Steven Serge
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-08-14 13:18 Tx date 2025-06-10 |
$CIII
Cytophage Technologies Ltd. |
Theriault, Natasha Helena
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$200,000
+500,000 vol $0.40 each |
500,000 | |
| Filed 2025-08-14 13:14 Tx date 2024-02-09 |
$CIII
Cytophage Technologies Ltd. |
Theriault, Natasha Helena
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-08-12 18:40 Tx date 2025-07-31 |
$CIII
Cytophage Technologies Ltd. |
COCHRANE, MICHAEL
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+75,000 vol |
175,000 | |
| Filed 2025-08-12 18:36 Tx date 2024-04-15 |
$CIII
Cytophage Technologies Ltd. |
COCHRANE, MICHAEL
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2025-08-07 09:03 Tx date 2024-04-12 |
$CIII
Cytophage Technologies Ltd. |
Snisarenko, John
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2025-08-05 21:22 Tx date 2025-07-31 |
$CIII
Cytophage Technologies Ltd. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
+50,000 vol |
300,000 | |
| Filed 2025-08-05 16:35 Tx date 2025-07-31 |
$CIII
Cytophage Technologies Ltd. |
Ollerhead, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+50,000 vol |
323,133 |